Retrospective Study of Chidamide as First-Line Maintenance Therapy for Peripheral T-cell Lymphoma in Adults

What this Trial Is About

This research aims to evaluate the safety and effectiveness of chidamide when used as a first-line maintenance therapy for patients diagnosed with peripheral T-cell lymphoma PTCL. The study involves a retrospective analysis, collecting past patient data to better understand how chidamide works in this specific treatment setting. Researchers collected detailed information from patients diagnosed with PTCL who received chidamide as maintenance therapy after their initial treatment. The data includes demographics, prior treatments, and results from various tests such as blood work, bone marrow studies, pathology, flow cytometry, next-generation sequencing, and PET-CT scans. The study focuses on assessing chidamides role during this maintenance phase. Participants medical records are reviewed for several outcomes, including progression-free survival over two years, overall survival, complete response rates, and duration of response. Safety data is also analyzed based on these records. This retrospective study does not require active treatment or visits but involves thorough examination of existing clinical data collected at the study center.

A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.